Michael Higgins has served on the board of directors since July 2015 and as chair of the board since June 2019. He is currently also the chairman of the board of Pulmatrix, Inc. and a board member at Genocea Biosciences, Nocion Therapeutics, Camp4 Therapeutics and Sea Pharmaceuticals. Michael previously served as Entrepreneur-in-Residence at Polaris Partners.  He also served as Senior Vice President, Chief Operating Officer of Ironwood Pharmaceuticals Inc. and held a variety of senior business positions at Genzyme Corporation, including Vice President of Corporate Finance and Vice President of Business Development. Prior to joining Genzyme Corporation, Michael led Procept, Inc.’s financial team. Michael has a B.S. from Cornell University and an M.B.A. from the Amos Tuck School of Business Administration at Dartmouth College.